Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Financial Services
The Early Wave of AI in Healthcare Belongs to Startups. For Now.
Healthcare went from digital laggard to one of the fastest adopters of applied AI, and we break down why the shift happened and who’s actually benefiting.
December 3, 2025
DeciBio Q&A
Financial Services
The Early Wave of AI in Healthcare Belongs to Startups. For Now.
Healthcare went from digital laggard to one of the fastest adopters of applied AI, and we break down why the shift happened and who’s actually benefiting.
December 3, 2025
AI / Machine Learning
DeciBio News
Pharma & Biotech
GenomeWeb Best Places to Work Winner, 26-50 Employees: DeciBio 2025
DeciBio is named a GenomeWeb Best Place to Work in 2025.
November 19, 2025
DeciBio News
Pharma & Biotech
GenomeWeb Best Places to Work Winner, 26-50 Employees: DeciBio 2025
DeciBio is named a GenomeWeb Best Place to Work in 2025.
November 19, 2025
Life Science Consulting
Weekly News
DeciBio News
Newsletter Update
Financial Services
Investing in Precision Medicine: VC | PE | M&A - October Round-Up 2025
October 2025 marked a period of intense deal-making across the life sciences, driven by robust financing and aggressive capital plays, primarily focusing on metabolic disease and advanced oncology.
November 19, 2025
Newsletter Update
Financial Services
Investing in Precision Medicine: VC | PE | M&A - October Round-Up 2025
October 2025 marked a period of intense deal-making across the life sciences, driven by robust financing and aggressive capital plays, primarily focusing on metabolic disease and advanced oncology.
November 19, 2025
Precision Medicine
DeciBio Ventures
Private Equity
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Round-Up 2025
Liquid Biopsy (LBx) continued to develop through October, featuring new regulatory approvals and partnerships as well as trial launches and study results.
November 13, 2025
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Round-Up 2025
Liquid Biopsy (LBx) continued to develop through October, featuring new regulatory approvals and partnerships as well as trial launches and study results.
November 13, 2025
Liquid Biopsy
DeciBio Q&A
Clinical Diagnostics
Current Perspective on Comprehensive Genomic Testing - Q&A with Premal Shah, Ph.D., CEO at MyOme
We recently interviewed Premal Shah, Ph.D., CEO of MyOme, a precision health company providing whole‑genome sequencing testing for proactive risk assessments, alongside clinical diagnostics offerings.
November 13, 2025
DeciBio Q&A
Clinical Diagnostics
Current Perspective on Comprehensive Genomic Testing - Q&A with Premal Shah, Ph.D., CEO at MyOme
We recently interviewed Premal Shah, Ph.D., CEO of MyOme, a precision health company providing whole‑genome sequencing testing for proactive risk assessments, alongside clinical diagnostics offerings.
November 13, 2025
Genomics Market
.png)
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics | October Round-Up 2025
October 2025 brought new developments across the digital health landscape!
November 12, 2025
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics | October Round-Up 2025
October 2025 brought new developments across the digital health landscape!
November 12, 2025
Digital Health
Health Technology Market
Women's Health
Medical Devices
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved